Page last updated: 2024-08-26

1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole and Cardiomegaly

1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole has been researched along with Cardiomegaly in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barr, LA; Berretta, RM; Gao, H; Houser, SR; Kubo, H; Makarewich, CA; Molkentin, JD; Wang, F; Wang, W; Zhang, H1

Other Studies

1 other study(ies) available for 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole and Cardiomegaly

ArticleYear
Ca(2+) influx through L-type Ca(2+) channels and transient receptor potential channels activates pathological hypertrophy signaling.
    Journal of molecular and cellular cardiology, 2012, Volume: 53, Issue:5

    Topics: Animals; Calcineurin; Calcineurin Inhibitors; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Calcium Signaling; Cardiomegaly; Cell Nucleus; Cells, Cultured; Heart Ventricles; Imidazoles; Myocytes, Cardiac; NFATC Transcription Factors; Nickel; Nifedipine; Protein Transport; Rats; Rats, Sprague-Dawley; Tacrolimus; TRPC Cation Channels; Ventricular Remodeling

2012